17.11.2012
- The U.S. Federal Trade Commission has cleared Valeant Pharmaceuticals International's $2.6 billion deal to buy U.S. dermatology rival Medicis Pharmaceutical, without conditions...
04.09.2012
- Valeant Pharmaceuticals International agreed on Monday to buy Medicis Pharmaceutical for $2.6 billion in cash, in a deal that will add Botox competitor Dysport and other skin care...
